Quantities of CD3+, CD8+ and CD56+ lymphocytes decline in breast cancer recurrences while CD4+ remain similar
Minna Mutka(University of Helsinki), Päivi Heikkilä(University of Helsinki)
Cited by 6
Related Papers
Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies
|JNCI Journal of the National Cancer Institute|2010|716
Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study
|Breast Cancer Research|2011|228
NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer
|Nature Genetics|2008|208
Clever-1 positive macrophages in breast cancer
|Breast Cancer Research and Treatment|2022|7